Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2009, Article ID 796206, 6 pages
Research Article

Trends in Method of Diagnosis of Type 2 Diabetes Mellitus: Results from SHIELD

1Endocrine & Metabolic Consultants, Rockville, MD 20852, USA
2Midwestern Endocrinology, Overland Park, KS 66211, USA
3Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
4AstraZeneca LP, Wilmington, DE 19803, USA

Received 30 September 2008; Revised 25 January 2009; Accepted 10 March 2009

Academic Editor: Robert R. Henry

Copyright © 2009 Helena W. Rodbard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aims. This study assessed whether recent screening recommendations have led to increased diagnosis of type 2 diabetes mellitus (T2DM) through routine screening. Methods. Respondents to the 2006 US SHIELD survey reported whether a physician told them they had T2DM, age at diagnosis, specialty of the physician who made the diagnosis, and whether the diagnosis was made after having symptoms, during routine screening, or when being treated for another health problem. Results. Of 3 022 T2DM respondents, 36% of respondents reported that T2DM diagnosis was made during routine screening alone, 20% after having symptoms alone, and 6% when being treated for another health problem alone. The proportion of T2DM respondents reporting a diagnosis based only on screening increased approximately 42% over a 15+-year time span (absolute increase from 31% to 44%) ( ), whereas symptom-based diagnosis did not change significantly ( ). T2DM was diagnosed primarily by family physicians (88.3%). Conclusion. These findings highlight the importance of regular screening for diabetes and the vital role of primary care physicians in recognizing individuals with T2DM.